Heightened innate immunity may trigger chronic inflammation, fatigue and post-exertional malaise in ME/CFS.
Che, Xiaoyu, Ranjan, Amit, Guo, Cheng et al. · npj metabolic health and disease · 2025 · DOI
Quick Summary
This study examined blood samples and immune responses in ME/CFS patients to understand why they experience extreme fatigue and feeling worse after activity. Researchers found that patients' immune systems overreact to germs, their bodies have trouble producing energy efficiently, and they have several chemical imbalances in their blood. These problems got worse after exercise and matched how sick patients felt.
Why It Matters
This study identifies potential biological mechanisms underlying ME/CFS and post-exertional malaise, moving beyond dismissing the condition as psychological. The findings could guide development of targeted treatments for specific pathways rather than symptomatic management alone, offering hope for more effective interventions.
Observed Findings
- Exaggerated innate immune response to microbial antigens in ME/CFS patients compared to controls
- Impaired energy production across multiple pathways (citric acid cycle, fatty acid oxidation, amino acid metabolism)
- Systemic inflammation linked to abnormal lipid levels and disrupted extracellular matrix homeostasis
- Redox imbalance with dysfunction in copper-dependent antioxidant defenses
- Many biomarkers showed worse abnormalities following exercise and correlated with symptom intensity
Inferred Conclusions
- Heightened innate immune activation may trigger and perpetuate chronic inflammation in ME/CFS
- Multiple energy metabolism pathways are simultaneously impaired, contributing to fatigue and post-exertional symptom worsening
- Dysregulation of tryptophan-serotonin-kynurenine pathways may contribute to cognitive and mood symptoms
- These interconnected metabolic and immune abnormalities identify potential targets for therapeutic intervention
Remaining Questions
- Do these biomarker abnormalities represent primary disease mechanisms or secondary consequences of chronic illness?
- Which abnormalities are most critical for triggering post-exertional malaise, and can they be individually targeted therapeutically?
- How do these findings differ across ME/CFS patient subgroups, and do they predict treatment response?
- Can normalizing specific metabolic or immune pathways reverse symptom progression or improve exercise tolerance?
What This Study Does Not Prove
This mechanistic study identifies associations between biomarkers and symptoms but does not prove causation—abnormal metabolites may be consequences rather than causes of ME/CFS. The study does not establish whether these findings apply to all ME/CFS patients or explain how the condition initiates in the first place. Exercise-induced worsening of biomarkers requires validation in larger, more diverse populations before clinical application.
Topics
Tags
Metadata
- DOI
- 10.1038/s44324-025-00079-w
- PMID
- 40903540
- Review status
- Editor reviewed
- Evidence level
- Early hypothesis, preprint, editorial, or weak support
- Last updated
- 7 April 2026